US Travelers Health Research, Surveillance, Communication, and Outreach Network
Open Closes November 5, 2026 (5 days left)
Centers for Disease Control and Prevention - ERA is offering grants of up to $1.0 million (at least $750,000) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expects to make one award worth $5.0 million in total. Applications close on November 5, 2026.
From the official notice on Grants.gov, last changed August 5, 2026. Checked October 31, 2026.
- Award ceiling$1.0 million
- Award floor$750,000
- Expected awards1
- Total funding$5.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | August 5, 2026 |
|---|---|
| Deadline | November 5, 2026 |
| Archived by Grants.gov | December 7, 2026 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The NOFO supports CDC"s efforts to protect U.S. residents traveling internationally. The goal is to help U.S. travelers with pre-travel preparation, access to timely health information while traveling, and timely research on health conditions. The project will:Improve access to high quality travel preparation information for both healthcare providers and travelers. Collect health information before, during, and after travel through innovative electronic medical record (EMR), web, and mobile phone applications. Build on this platform to conduct timely research on emerging health threats. This NOFO will also increase the awareness of travel medicine among primary care providers and provide them with appropriate tools in advising international travelers with up-to-date recommendations.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Centers for Disease Control and Prevention - ERA, RYork@cdc.gov, 404-498-2015.
Questions people ask
Who can apply for US Travelers Health Research, Surveillance, Communication, and Outreach Network?
Centers for Disease Control and Prevention - ERA accepts applications from nonprofits, colleges and universities, state and local governments, tribes and businesses.
What is the deadline for US Travelers Health Research, Surveillance, Communication, and Outreach Network?
Closes November 5, 2026 (5 days left). Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $1.0 million each. About $5.0 million in total for one award.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience